Bonnie Strelitz1, Jesse Gritton2, Eileen J Klein3, Miranda C Bradford2, Kristin Follmer2, Danielle M Zerr3, Janet A Englund3, Douglas J Opel4. 1. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, United States. Electronic address: bonnie.strelitz@seattlechildrens.org. 2. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, United States. 3. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, United States; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States. 4. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, United States; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States; Treuman Katz Center for Pediatric Bioethics, Seattle, WA, United States.
Abstract
BACKGROUND: Providing influenza vaccine to patients in the pediatric emergency department (PED) is one strategy to increase childhood influenza vaccine uptake. The Parent Attitudes about Childhood Vaccines (PACV) survey is a new tool to identify vaccine-hesitant parents that may facilitate influenza vaccine uptake in the PED. OBJECTIVE: To assess the feasibility of administering the PACV modified for influenza vaccination in the PED setting and to determine whether parental PACV scores are associated with patient receipt of influenza vaccine in the PED. METHODS: We conducted a cross-sectional study in the PED of a tertiary pediatric hospital in Seattle, WA during the 2013-2014 influenza season. English-speaking parents of children aged 6 months to 7 years who were afebrile, medically stable to be discharged home from the PED, and had not already received an influenza vaccine this season were administered a modified version of the PACV. PACV scores (0-100, higher score=higher hesitancy) were dichotomized (<50 and ≥50) consistent with previous validation studies. Feasibility was assessed by determining time to complete the PACV. Our primary outcome was influenza vaccine refusal in the PED. We used multivariable logistic regression to estimate unadjusted and adjusted odds ratios for association between vaccine refusal and dichotomized PACV scores. RESULTS: 152 parent participants were included in the analysis. The median time for administering the PACV was 7 min. The median PACV score was 28, with 74% scoring <50. Parents who scored ≥50 on the PACV had increased odds of refusing the influenza vaccine compared to parents who scored <50 (adjusted OR [95% CI]: 6.58 [2.03-21.38]). CONCLUSION: Administration of the PACV in the PED is feasible, and higher PACV scores in this setting are associated with increased influenza vaccine refusal.
BACKGROUND: Providing influenza vaccine to patients in the pediatric emergency department (PED) is one strategy to increase childhood influenza vaccine uptake. The Parent Attitudes about Childhood Vaccines (PACV) survey is a new tool to identify vaccine-hesitant parents that may facilitate influenza vaccine uptake in the PED. OBJECTIVE: To assess the feasibility of administering the PACV modified for influenza vaccination in the PED setting and to determine whether parental PACV scores are associated with patient receipt of influenza vaccine in the PED. METHODS: We conducted a cross-sectional study in the PED of a tertiary pediatric hospital in Seattle, WA during the 2013-2014 influenza season. English-speaking parents of children aged 6 months to 7 years who were afebrile, medically stable to be discharged home from the PED, and had not already received an influenza vaccine this season were administered a modified version of the PACV. PACV scores (0-100, higher score=higher hesitancy) were dichotomized (<50 and ≥50) consistent with previous validation studies. Feasibility was assessed by determining time to complete the PACV. Our primary outcome was influenza vaccine refusal in the PED. We used multivariable logistic regression to estimate unadjusted and adjusted odds ratios for association between vaccine refusal and dichotomized PACV scores. RESULTS: 152 parent participants were included in the analysis. The median time for administering the PACV was 7 min. The median PACV score was 28, with 74% scoring <50. Parents who scored ≥50 on the PACV had increased odds of refusing the influenza vaccine compared to parents who scored <50 (adjusted OR [95% CI]: 6.58 [2.03-21.38]). CONCLUSION: Administration of the PACV in the PED is feasible, and higher PACV scores in this setting are associated with increased influenza vaccine refusal.
Authors: P A Briss; L E Rodewald; A R Hinman; A M Shefer; R A Strikas; R R Bernier; V G Carande-Kulis; H R Yusuf; S M Ndiaye; S M Williams Journal: Am J Prev Med Date: 2000-01 Impact factor: 5.043
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Douglas J Opel; Rita Mangione-Smith; James A Taylor; Carolyn Korfiatis; Cheryl Wiese; Sheryl Catz; Diane P Martin Journal: Hum Vaccin Date: 2011-04-01
Authors: Amanda F Dempsey; Sarah Schaffer; Dianne Singer; Amy Butchart; Matthew Davis; Gary L Freed Journal: Pediatrics Date: 2011-10-03 Impact factor: 7.124
Authors: Mary Patricia Nowalk; Richard K Zimmerman; Chyongchiou J Lin; Feng Shou Ko; Mahlon Raymund; Alejandro Hoberman; Diana H Kearney; David P Greenberg Journal: Am J Prev Med Date: 2005-10 Impact factor: 5.043
Authors: Gretchen J Domek; Sean T O'Leary; Sheana Bull; Michael Bronsert; Ingrid L Contreras-Roldan; Guillermo Antonio Bolaños Ventura; Allison Kempe; Edwin J Asturias Journal: Vaccine Date: 2018-07-27 Impact factor: 3.641
Authors: Allison Kempe; Alison W Saville; Christina Albertin; Laura Helmkamp; Xinkai Zhou; Sitaram Vangela; L Miriam Dickinson; Chi-Hong Tseng; Jonathan D Campbell; Melanie Whittington; Dennis Gurfinkel; Heather Roth; Dina Hoefer; Peter Szilagyi Journal: Acad Pediatr Date: 2019-11-05 Impact factor: 3.107
Authors: Ekaterina Nekrasova; Melissa S Stockwell; Russell Localio; Justine Shults; Chelsea Wynn; Laura P Shone; Lindsay Berrigan; Chelsea Kolff; Miranda Griffith; Andrew Johnson; Alessandra Torres; Douglas J Opel; Alexander G Fiks Journal: Hum Vaccin Immunother Date: 2020-02-04 Impact factor: 3.452
Authors: Peter G Szilagyi; Christina S Albertin; Alison W Saville; Rebecca Valderrama; Abigail Breck; Laura Helmkamp; Xinkai Zhou; Sitaram Vangala; L Miriam Dickinson; Chi-Hong Tseng; Jonathan D Campbell; Melanie D Whittington; Heather Roth; Cynthia M Rand; Sharon G Humiston; Dina Hoefer; Allison Kempe Journal: J Pediatr Date: 2020-06 Impact factor: 4.406
Authors: Rebecca J Hart; Michelle D Stevenson; Michael J Smith; A Scott LaJoie; Keith Cross Journal: JAMA Pediatr Date: 2018-01-02 Impact factor: 16.193
Authors: Victoria O Olarewaju; Kristen Jafflin; Michael J Deml; Clara Zimmermann; Joanna Sonderegger; Thierry Preda; Hanna Staub; Marek Kwiatkowski; Andrea Kloetzer; Benedikt M Huber; Sonja Merten; Philip E Tarr Journal: Hum Vaccin Immunother Date: 2021-03-24 Impact factor: 3.452